BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 28704779)

  • 1. Diagnostic value of circulating tumor DNA in molecular characterization of glioma: A meta-analysis.
    Kang Y; Lin X; Kang D
    Medicine (Baltimore); 2020 Aug; 99(33):e21196. PubMed ID: 32871983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic Value of Circulating miR-29 Family for Digestive System Malignancies: A Meta-Analysis.
    Zou S; Chen F; Zhang L; Liu C; Chen H
    Lab Med; 2024 Jan; 55(1):1-7. PubMed ID: 37172311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta-analysis.
    Feng Y; Wang J; Tan D; Cheng P; Wu A
    Cancer Med; 2019 Dec; 8(17):7454-7468. PubMed ID: 31599129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Spirochete
    Aravindraja C; Jeepipalli S; Vekariya KM; Botello-Escalante R; Chan EKL; Kesavalu L
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of Exosomes as Future Therapeutic Agents and Diagnostic Tools for Glioma.
    Wu X; Wang X; Wang J; Hao Y; Liu F; Wang X; Yang L; Lu Z
    Front Oncol; 2021; 11():733529. PubMed ID: 34722277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Expression of hsa-miR-338-3p Contributes to the Development of Glioma Cells by Targeting Mitochondrial 3-Oxoacyl-ACP Synthase (OXSM) in Glioblastoma (GBM).
    Wang WY; Lu WC
    Onco Targets Ther; 2020; 13():9513-9523. PubMed ID: 33061435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review.
    Raza IJ; Tingate CA; Gkolia P; Romero L; Tee JW; Hunn MK
    Front Oncol; 2020; 10():1191. PubMed ID: 32923382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data.
    Liu W; Xu Z; Zhou J; Xing S; Li Z; Gao X; Feng S; Xiao Y
    Front Oncol; 2020; 10():627. PubMed ID: 32457836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-128 as a potential diagnostic biomarker for glioma.
    Liang RF; Li M; Yang Y; Wang X; Mao Q; Liu YH
    Clin Neurol Neurosurg; 2017 Sep; 160():88-91. PubMed ID: 28704779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
    Qu S; Guan J; Liu Y
    J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.